Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Anticancer Research
|
September 2, 1999
Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells
W C Welch, P L Kornblith, G K Michalopoulos, et al.
Cancer Research
|
October 15, 1995
Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy
U Nannmark, B R Johansson, J L Bryant, et al.
Anticancer Research
|
September 2, 1999
Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles
R H Goldfarb, R P Kitson, K W Brunson, et al.
Immunology
|
August 6, 2000
2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness
S S Chuang, M H Kim, L A Johnson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 23, 2000
Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors
M H Kim, R P Kitson, P Albertsson, et al.
In Vivo (Athens, Greece)
|
April 11, 2000
Matrix metalloproteinases of human NK cells
P Albertsson, M H Kim, L E Jonges, et al.
Journal of Cellular Biochemistry
|
May 1, 1994
Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex
K Wasserman, R P Kitson, A J Rivett, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 6, 2000
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo
Y Guo, A A Higazi, A Arakelian, et al.
Scandinavian Journal of Immunology
|
September 14, 2007
Differential locomotion of long- and short-term IL-2-activated murine natural killer cells in a model matrix environment
P Albertsson, P H Basse, K Edsparr, et al.
In Vivo (Athens, Greece)
|
April 11, 2000
A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin
R H Goldfarb, R Koelemij, K A Muirhead, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Anticancer Research
|
September 2, 1999
Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells
W C Welch, P L Kornblith, G K Michalopoulos, et al.
Cancer Research
|
October 15, 1995
Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy
U Nannmark, B R Johansson, J L Bryant, et al.
Anticancer Research
|
September 2, 1999
Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles
R H Goldfarb, R P Kitson, K W Brunson, et al.
Immunology
|
August 6, 2000
2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness
S S Chuang, M H Kim, L A Johnson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 23, 2000
Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors
M H Kim, R P Kitson, P Albertsson, et al.
In Vivo (Athens, Greece)
|
April 11, 2000
Matrix metalloproteinases of human NK cells
P Albertsson, M H Kim, L E Jonges, et al.
Journal of Cellular Biochemistry
|
May 1, 1994
Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex
K Wasserman, R P Kitson, A J Rivett, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 6, 2000
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo
Y Guo, A A Higazi, A Arakelian, et al.
Scandinavian Journal of Immunology
|
September 14, 2007
Differential locomotion of long- and short-term IL-2-activated murine natural killer cells in a model matrix environment
P Albertsson, P H Basse, K Edsparr, et al.
In Vivo (Athens, Greece)
|
April 11, 2000
A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin
R H Goldfarb, R Koelemij, K A Muirhead, et al.
Page
of 8